RNaseH2 inhibition potentiates temozolomide response in patient derived glioblastoma cells.
RNaseH2 抑制剂可增强替莫唑胺对患者来源的胶质母细胞瘤细胞的反应。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-25298-5
Kissova Miroslava, Martinez Segarra Judit, Iveland Tobias Solli, Vestvik Marthe, Ravlo Erlend, Wang Wei, Hagen Lars, Liabakk Nina-Beate, Camara-Quilez Maria, Arano Barenys Miquel, Solheim Ole, Hoff Bård Helge, Sundby Eirik, Bjørås Magnar, Slupphaug Geir, Visnes Torkild, Brambilla Alessandro
